Cytyc Corporation - Case Presentation Archive - July 2002

Similar documents
Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Histopathology: Cervical HPV and neoplasia

CINtec p16 INK4a Staining Atlas

Cytyc Corporation - Case Presentation Archive - October 2001

Cytyc Corporation - Case Presentation Archive - March 2002

Gynecologic Cytopathology: Glandular lesions

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000

Chapter 10: Pap Test Results

LGM International, Inc.

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Clinical Practice Guidelines June 2013

The ABCs of TBS. A Novice's Guide to the Bethesda System

Cytology Report Format

Understanding Your Pap Test Results

Prepared By Jocelyn Palao and Layla Faqih

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

Cytyc Corporation - Case Presentation Archive - June 2003

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Cervical Cancer : Pap smear

Demystifying Endometrial Hyperplasia

Cervical Dysplasia and HPV

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Glandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Cervical Cancer Screening. David Quinlan December 2013

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

Colposcopy. Attila L Major, MD, PhD

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

BOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo. Case Discussions. 60 year old woman Routine gynecologic control LBC

In situ and Invasive Endocervical Carcinoma: Problems and Pitfalls in Diagnosis

Case 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Villoglandular adenocarcinoma of cervix a tumour with bland cytological features: report of a case missed on cytology

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

Morphology I Slide: 1

BC Cancer Cervix Screening 2015 Program Results. February 2018

CPC on Cervical Pathology

Cervical Conization. 1

Atypical Hyperplasia/EIN

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

Maturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : :

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Making Sense of Cervical Cancer Screening

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Done by khozama jehad. Neoplasia of the cervix

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Received, June 29, 1904; accepted for publication

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

Cervical Precancer: Evaluation and Management

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology

Thyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear

Conflict of Interest 9/7/2018. Dr. Mody 1. None with vendors of cytology equipment/testing/vaccines Amirsys (now Elsevier)

EU guidelines for reporting gynaecological cytology

What is a Pap smear?

Diagnostically Challenging Cases in Gynecologic Pathology

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS

Eradicating Mortality from Cervical Cancer

A cyto-histopathological correlation study of lesions of uterine cervix

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Cervical Cytology Preparations

Estimated New Cancers Cases 2003

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Endometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Cytology and Surgical Pathology of Gynecologic Neoplasms

Your Colposcopy Visit

Medullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands

Becoming a colposcopist: Colposcope case studies

When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

The diagnostic category of atypical squamous cells of undetermined

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

I have no financial interests to disclose.

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

HPV: cytology and molecular testing

Salivary Glands 3/7/2017

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

Management that provides continuity of care for women

Cervical cytology screening has led to a reduction in cancer mortality

Index. Cytoplasm, nonepithelial malignant tumor features 70

Gynaecological Malignancies

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

ACGME Competency / Milestone Assessment. The Pap Test. Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Outline 11/2/2017. Pancreatic EUS-FNA general aspects. Cytomorphologic features of solid neoplasms/lesions of the pancreas

Mody. Atypical Glandular Cells(TBS 2001) Adenocarcinoma In Situ(TBS 2001)

Management of Abnormal Cervical Cytology and Histology

What Causes Cervical Cancer? Symptoms of Cervical Cancer

Diagnostics: The Effect on Evidence Based Clinical Pathways. DNA vs Disease. Bruce K. Pa+erson MD CEO and President, IncellDx, Inc.

Transcription:

ThinPrep Pap Test History: 34 Year Old Female LMP: Day 20 Specimen Type: Cervical/Vaginal Case provided by Mark Tulecke, M.D. and Gabrielle Trawinski CT (ASCP), Mount Auburn Hospital, Cambridge, Massachusetts. *The images, analysis and diagnosis for this case study were provided to Cytyc by an independent physician. All conclusions and opinions are those of Mount Auburn Hospital and not Cytyc Corporation. Slide 1-60x Slide 2-60x

Slide 3-60x Slide 4-60x

Slide 5-60x Slide 6-20x

Slide 7-10x Slide 8-10x

Discussion: Slide 1: Short strip of crowded cells with elongated, hyperchromatic nuclei, high N/C ratio, moderately coarse even chromatin and micronucleoli. There is a suggestion of feathering as the elongated nuclei are on the periphery and level with each other. Slide 2: Cell groups displaying different architectural forms. On the left, a short strip and rosette; On the right, a 3D syncytial type aggregate with a possible gland opening. Slide 3: A single strip of atypical glandular cells with coarse even chromatin and pseudostratification, falsely appearing to have many layers due to crowding and slight overlap of the nuclei. Slide 4: Side A shows a loosely cohesive group of cells that are more polygonal and flat than group B. It also is less papillary appearing, has more distinct cytoplasmic borders, central nuclei and more variation in size and chromatin pattern than group B. Slide 5: Group of flat cells showing polygonal cytoplasm with distinct cell borders, high N/C ratio, coarse evenly distributed chromatin and irregular nuclear membranes. Slide 6: Overview showing a background of numerous single high N/C ratio cells in the white spaces. Slide 7: Tissue section showing crowded glands with atypical hyperchromatic nuclei. Slide 8: Tissue section showing high grade squamous intraepithelial lesion invading the gland crypts. Cytologic Diagnosis: Atypical Glandular Cells of Undetermined Significance. Small atypical squamous metaplastic cells suspicious for high-grade squamous intraepithelial lesion. Cannot exclude glandular extension of squamous dysplasia. Cervical Cone Biopsy: Adenocarcinoma In-Situ High grade squamous intraepithelial lesion with the involvement of endocervical glands (CIN III). Adenocarcinoma In Situ (AIS) occurs when: the epithelial cells and/or glands are lined with abnormal cells, the normal interrelationship of the glands is maintained and when there is no invasion into the stroma.the cell of origin is the same as squamous epithelial lesions, the subcolumnar reserve cell or multipotential cell. The progression from normal endocervical cells to frankly invasive adenocarcinoma are thought to involve 3 intermediate steps: endocervical dyplasia, adenocarcinoma in-situ and microinvasive adenocarcinoma. However, adenocarcinoma may also arise with out a precursor, arising directly from the cells of origin.

AIS was first described histologically as an entity in 1953 by Friedell and McKay. The following criteria that suggests AIS as a precursor to endocervical adenocarcinoma are from their studies and other well established studies: 1) Histologically, AIS resembles carcinoma but without demonstrable invasion of the stroma. 2) Similar morphologic changes occur at the periphery of invasive adenocarcinoma. 3) An in situ lesion can be followed through to its development into an invasive adenocarcinoma. 4) Cytologic features of exfoliated cells from histologically proven in-situ lesions to those found in smears from patients with microinvasive and invasive carcinoma of the same type are similar. 5) The average age of patients with AIS is several years younger than that of patients with invasive cancer suggesting that the in-situ form precedes the development of the invasive form of cancer. It would be a conclusion to link the factors of frankly invasive endocervical adenocarcinoma to its precursor lesions. Studies suggest that their may be 2 different factor lines of progression of adenocarcinoma:hpv and hormones. Like squamous lesions, there is a strong association with HPV, particularly HPV 18 for glandular lesions. However, there does not seem to be as strong an association with other squamous factors such as early age of 1st intercourse, sexual activity, or smoking. Like endometrial lesions, there is a strong hormonal association and other endometrial risk factors namely, a more affluent socioeconomic background with significantly more education, nulliparity, overweight, possible hypertension, diabetes and progesterone. The mean age for AIS is 37 but that statistic may be falling. The frequency of glandular lesions is increasing significantly while the incidence of cervical squamous carcinoma is decreasing. However, precursor glandular lesion frequency is still less than for outspoken adenocarcinoma. Endocervical adenocarcinoma now accounts for up to 1/3 of all invasive cervical cancers. Studies show that AIS involves some or all of the transformation zone if there is an accompanying squamous abnormality and up to 50% of glandular lesions are associated with an abnormal squamous epithelial lesion. The accompanying squamous abnormality may extend into the gland crypts and replace or partially replace the indigenous cells and take on a similar morphologic appearance (elongated nuclei, false feathering, syncytial-like aggregates etc.) possibly due to the same environmental tight constrictions of a gland. This makes an accurate cytological diag-

nosis difficult whereas the histological diagnosis is a little more clear cut as to what is a true glandular lesion and what is squamous with gland involvement. Otherwise, the lesion usually arises contiguous with the squamo-columnar junction. However, as the transformation zone recedes into the endocervical canal with age (usually women over 35), early detection by endocervical scraping and colposcopy becomes more difficult (giving rise to the statistic that glandular precursor lesion frequency is less than adenocarcinoma). Also the deep glands tend to be more involved than the surface, which can affect both cytologic and histologic sampling. The lesions can also be very focal, particularly when in-situ. Unfortunately, these factors give the pap smear a false negative rate as high as 50% in patients with grossly identifiable lesions (as high as 80% if there is no gross lesion). Fortunately, the abnormal endocervical cells that do make it on a slide, are much more accurately detected with improved pap test preparation technology; decreasing false negative rates due to interpretation error. References: 1) Demay, Richard. The Art and Science of Cytopathology. 1996:127-133 2) McKee, Grace T. Cytopathology.1997:56-57 3) Bibbo,Marluce., MD. Comprehensive Cytopathology.1990:231-249 4) Keebler, Catherine.,Somrak,Theresa. The Manual of Cytotechnology 7th edition. 1993:129-137